Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review
Journal of Gastroenterology and Hepatology · 2025-01 · 40 (1) · 33-40
DOI: 10.1111/jgh.16750 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 29.09.2024. Verfasst von Jie-Lun Ku und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Bile Acids and Salts, Gastrointestinal Microbiome, Fatty Liver, Receptors, Interleukin-1 Type I. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology, National Science and Technology Council, Yen Tjing Ling Medical Foundation.
Abstract (Originalsprache)
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a prevalent metabolic disorder characterized by hepatic steatosis associated with metabolic abnormalities. Recent research has shed light on the intricate interplay among interleukin‐1 receptor 1 (IL1R1), gut microbiota, and bile acids in the pathogenesis of MASLD. This review aims to provide a comprehensive overview of the current understanding of the role of IL1R1, gut microbiota, and bile acids in MASLD, exploring their interrelationships and potential mechanisms. We summarize the evidence supporting the involvement of IL1R1 in inflammation, discuss the influence of gut microbiota on bile acid metabolism and its influence on liver health, and elucidate the bidirectional interactions among IL1R1 signaling, gut microbiota composition, and bile acid homeostasis in MASLD. Furthermore, we highlight emerging therapeutic strategies targeting these interrelated pathways for the management of MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department and Institute of Physiology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, 100, Taiwan.
- Health Innovation Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Microbiota Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
ORCID-Profile: Jie-Lun Ku, Jia-Rou Hsu, Yung-Tsung Li, Li-Ling Wu
Förderung
- Ministry of Science and Technology
- National Science and Technology Council
- Yen Tjing Ling Medical Foundation
Zitieren
APA
Ku, J. L., Hsu, J. R., Li, Y. T., & Wu, L. L. (2025). Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review. Journal of Gastroenterology and Hepatology, 40(1), 33-40. https://doi.org/10.1111/jgh.16750
Vancouver
Ku JL, Hsu JR, Li YT, Wu LL. Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review. Journal of Gastroenterology and Hepatology. 2025;40(1):33-40. doi:10.1111/jgh.16750
BibTeX
@article{Ku2025,
author = {Ku, Jie-Lun and Hsu, Jia-Rou and Li, Yung-Tsung and Wu, Li-Ling},
title = {Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
volume = {40},
number = {1},
pages = {33--40},
doi = {10.1111/jgh.16750}
}
EUVIMED